• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Geroscience and the trans-NIH Geroscience Interest Group, GSIG.衰老科学和跨 NIH 衰老科学兴趣小组(GSIG)。
Geroscience. 2017 Feb;39(1):1-5. doi: 10.1007/s11357-016-9954-6.
2
Moving Geroscience Into Uncharted Waters.将老年科学带入未知领域。
J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1385-1387. doi: 10.1093/gerona/glw087. Epub 2016 Aug 16.
3
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.生理老年科学:针对功能以延长健康寿命并实现最佳长寿。
J Physiol. 2016 Apr 15;594(8):2001-24. doi: 10.1113/jphysiol.2014.282665. Epub 2015 Mar 11.
4
Advances in geroscience: impact on healthspan and chronic disease.衰老科学的进展:对健康寿命和慢性疾病的影响。
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1(Suppl 1):S1-3. doi: 10.1093/gerona/glu041.
5
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives.在公共卫生实践中推广延寿补充剂和药物的实施:成就、挑战和未来展望。
J Transl Med. 2017 Jul 20;15(1):160. doi: 10.1186/s12967-017-1259-8.
6
Advances and challenges in geroscience research: An update.老年科学研究的进展与挑战:最新情况
Physiol Int. 2018 Dec 1;105(4):298-308. doi: 10.1556/2060.105.2018.4.32.
7
Geroscience: Addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis.老年科学:应对其令人兴奋的研究机遇、经济需求与当前资金危机之间的不匹配问题。
Exp Gerontol. 2017 Aug;94:46-51. doi: 10.1016/j.exger.2016.11.008. Epub 2016 Nov 19.
8
Creating the Next Generation of Translational Geroscientists.培养新一代转化老年医学科学家。
J Am Geriatr Soc. 2019 Sep;67(9):1934-1939. doi: 10.1111/jgs.16055. Epub 2019 Jul 9.
9
Moving geroscience from the bench to clinical care and health policy.推动衰老生物学从实验室走向临床护理和卫生政策。
J Am Geriatr Soc. 2021 Sep;69(9):2455-2463. doi: 10.1111/jgs.17301. Epub 2021 Jun 19.
10
The Role of the National Institute on Aging in the Development of the Field of Geroscience.国家老龄化研究所(National Institute on Aging)在老年科学领域发展中的作用。
Cold Spring Harb Perspect Med. 2023 Oct 3;13(10):a041211. doi: 10.1101/cshperspect.a041211.

引用本文的文献

1
Uncovering the multivariate genetic architecture of frailty with genomic structural equation modeling.运用基因组结构方程模型揭示衰弱的多变量遗传结构。
Nat Genet. 2025 Aug 4. doi: 10.1038/s41588-025-02269-0.
2
From frailty to resilience: exploring adaptive capacity and reserve in older adults-a narrative review.从脆弱到恢复力:探索老年人的适应能力和储备——一篇叙述性综述
Front Aging. 2025 Jul 1;6:1520842. doi: 10.3389/fragi.2025.1520842. eCollection 2025.
3
The Role of Nutraceuticals and Functional Foods in Mitigating Cellular Senescence and Its Related Aspects: A Key Strategy for Delaying or Preventing Aging and Neurodegenerative Disorders.营养保健品和功能性食品在减轻细胞衰老及其相关方面的作用:延缓或预防衰老及神经退行性疾病的关键策略。
Nutrients. 2025 May 28;17(11):1837. doi: 10.3390/nu17111837.
4
Bcl-xL overexpression in T cells preserves muscle mitochondrial structure and function and prevents frailty in old mice.T细胞中Bcl-xL的过表达可维持老年小鼠肌肉线粒体的结构和功能,并预防身体虚弱。
Sci Adv. 2025 Mar 21;11(12):eadr1378. doi: 10.1126/sciadv.adr1378. Epub 2025 Mar 19.
5
HIV and Inflamm-Aging: How Do We Reach the Summit of Healthy Aging?艾滋病病毒与炎症衰老:我们如何实现健康衰老的巅峰?
Top Antivir Med. 2024 Dec 23;32(5):589-596.
6
A brief report on biomarkers of cellular senescence associated with liver frailty and length of stay in liver transplantation.关于与肝脏脆弱性及肝移植住院时间相关的细胞衰老生物标志物的简要报告。
Geroscience. 2024 Dec 30. doi: 10.1007/s11357-024-01482-9.
7
[Association between factors in life course and physiological dysregulation among the middle-aged and older population in Zhoushan city of Zhejiang province].[浙江省舟山市中老年人群生命历程因素与生理失调的关联]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Jan 25;54(1):39-48. doi: 10.3724/zdxbyxb-2024-0168.
8
Non-pharmaceutical interventions and epigenetic aging in adults: Protocol for a scoping review.非药物干预和成年人的表观遗传衰老:系统评价方案。
PLoS One. 2024 Aug 19;19(8):e0301763. doi: 10.1371/journal.pone.0301763. eCollection 2024.
9
Role of the National Institute on Aging in Transforming Aging Research Through Geroscience and Gerotherapeutics-50 Years of Innovation.美国国立衰老研究所通过老年科学和老年治疗学在变革衰老研究中的作用——50年的创新
JAMA Intern Med. 2024 Oct 1;184(10):1146-1148. doi: 10.1001/jamainternmed.2024.2534.
10
Sociodemographic and Lifestyle Factors and Epigenetic Aging in US Young Adults: NIMHD Social Epigenomics Program.美国年轻成年人的社会人口学和生活方式因素与表观遗传衰老:NIMHD 社会表观基因组学计划。
JAMA Netw Open. 2024 Jul 1;7(7):e2427889. doi: 10.1001/jamanetworkopen.2024.27889.

本文引用的文献

1
Disease drivers of aging.衰老的疾病驱动因素。
Ann N Y Acad Sci. 2016 Dec;1386(1):45-68. doi: 10.1111/nyas.13299.
2
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.用弱雌激素激动剂、抗氧化剂、α-葡萄糖苷酶抑制剂或Nrf2诱导剂处理的雄性小鼠寿命延长。
Aging Cell. 2016 Oct;15(5):872-84. doi: 10.1111/acel.12496. Epub 2016 Jun 16.
3
Physical Functioning among Women 80 Years of Age and Older With and Without a Cancer History.有或无癌症病史的80岁及以上女性的身体机能
J Gerontol A Biol Sci Med Sci. 2016 Mar;71 Suppl 1(Suppl 1):S23-30. doi: 10.1093/gerona/glv073.
4
Geroscience: linking aging to chronic disease.衰老学:将衰老与慢性疾病联系起来。
Cell. 2014 Nov 6;159(4):709-13. doi: 10.1016/j.cell.2014.10.039.
5
Functional impairment, disability, and frailty in adults aging with HIV-infection.感染HIV的成年患者衰老过程中的功能障碍、残疾和衰弱
Curr HIV/AIDS Rep. 2014 Sep;11(3):279-90. doi: 10.1007/s11904-014-0215-y.
6
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy.衰老使肿瘤免疫治疗后急性炎症诱导的病理变化更容易发生。
J Exp Med. 2013 Oct 21;210(11):2223-37. doi: 10.1084/jem.20131219. Epub 2013 Sep 30.
7
The hallmarks of aging.衰老的特征。
Cell. 2013 Jun 6;153(6):1194-217. doi: 10.1016/j.cell.2013.05.039.
8
The role of inflammation in age-related disease.炎症在与年龄相关疾病中的作用。
Aging (Albany NY). 2013 Jan;5(1):84-93. doi: 10.18632/aging.100531.
9
Frailty defined by deficit accumulation and geriatric medicine defined by frailty.衰弱由积累的缺陷定义,老年医学由衰弱定义。
Clin Geriatr Med. 2011 Feb;27(1):17-26. doi: 10.1016/j.cger.2010.08.008.
10
Frailty in older adults: evidence for a phenotype.老年人的衰弱:一种表型的证据。
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

衰老科学和跨 NIH 衰老科学兴趣小组(GSIG)。

Geroscience and the trans-NIH Geroscience Interest Group, GSIG.

机构信息

Division of Aging Biology, National Institute on Aging, NIH, Bethesda, MD, USA.

出版信息

Geroscience. 2017 Feb;39(1):1-5. doi: 10.1007/s11357-016-9954-6.

DOI:10.1007/s11357-016-9954-6
PMID:28299635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5352582/
Abstract

Age is by far the major risk factor for most chronic diseases. This has been common knowledge since time immemorial. Aging encompasses the biological changes most often seen as declines of function and increasing burden of disease. The close linkage of these two has led people to believe that aging, like age, is immutable. It is only recently that research into the basic molecular and cellular mechanisms of aging has led to potential interventions that increase lifespan and appear to increase healthspan, as well. Geroscience is an interdisciplinary field that aims to understand the relationship between the biology of aging and the biology of age-related diseases. The "geroscience hypothesis" posits that manipulation of aging will delay (in parallel) the appearance or severity of many chronic diseases because these diseases share the same underlying major risk factor (age). The hope is that this will lead to health improvements in the older population with perhaps greater efficiency than can be achieved through the successful cure and management of diseases of aging as they arise individually or as comorbidities.With those concepts in mind, the Geroscience Interest Group (GSIG) was launched as a trans-institute interest group within the NIH in November 2012. Here, we discuss the genesis of the trans-NIH group and the most salient activities that have occurred in the last 5 years.

摘要

年龄是大多数慢性疾病的主要危险因素。自古以来,这一直是常识。衰老包括功能下降和疾病负担增加等常见的生物学变化。这两者的紧密联系导致人们认为衰老和年龄一样是不可改变的。直到最近,对衰老的基本分子和细胞机制的研究才导致了潜在的干预措施,这些干预措施不仅延长了寿命,而且似乎还延长了健康寿命。衰老科学是一个跨学科领域,旨在了解衰老生物学与与年龄相关疾病生物学之间的关系。“衰老科学假说”假设,对衰老的干预将(平行地)延迟许多慢性疾病的出现或严重程度,因为这些疾病具有相同的潜在主要危险因素(年龄)。人们希望这将导致老年人群的健康状况得到改善,其效率可能比通过成功治愈和管理随着年龄增长而单独出现或作为合并症出现的衰老疾病更高。基于这些概念,衰老科学兴趣小组(GSIG)于 2012 年 11 月作为 NIH 内部的跨机构兴趣小组成立。在这里,我们讨论了跨 NIH 小组的起源以及过去 5 年中发生的最显著的活动。